Grouzmann E - Search Results

1

Production and characterization of four anti-neuropeptide Y monoclonal antibodies.

Grouzmann E, Comoy E, Walker P, Burnier M, Bohuon C, Waeber B, Brunner H. Grouzmann E, et al. Hybridoma. 1992 Aug;11(4):409-24. doi: 10.1089/hyb.1992.11.409. Hybridoma. 1992. PMID: 1383123

2

A novel cyclic analog of neuropeptide Y specific for the Y2 receptor.

Beck-Sickinger AG, Grouzmann E, Hoffmann E, Gaida W, van Meir EG, Waeber B, Jung G. Beck-Sickinger AG, et al. Among authors: grouzmann e. Eur J Biochem. 1992 Jun 15;206(3):957-64. doi: 10.1111/j.1432-1033.1992.tb17006.x. Eur J Biochem. 1992. PMID: 1318842 Free article.

3

Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats.

Aubert JF, Walker P, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Aubert JF, et al. Among authors: grouzmann e. Clin Exp Pharmacol Physiol. 1992 Apr;19(4):223-8. doi: 10.1111/j.1440-1681.1992.tb00442.x. Clin Exp Pharmacol Physiol. 1992. PMID: 1325309

4

A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y.

Grouzmann E, Aubert JF, Waeber B, Brunner HR. Grouzmann E, et al. Peptides. 1992 Nov-Dec;13(6):1049-54. doi: 10.1016/0196-9781(92)90004-m. Peptides. 1992. PMID: 1494487

5

Plasma neuropeptide Y and catecholamine concentrations and urinary metanephrine excretion in patients with adrenal or ectopic phaeochromocytoma.

Plouin PF, Chatellier G, Grouzmann E, Azizi M, Denolle T, Comoy E, Corvol P. Plouin PF, et al. Among authors: grouzmann e. J Hypertens Suppl. 1991 Dec;9(6):S272-3. J Hypertens Suppl. 1991. PMID: 1818966 No abstract available.

6

The role of neuropeptide Y in cardiovascular regulation.

Walker P, Grouzmann E, Burnier M, Waeber B. Walker P, et al. Among authors: grouzmann e. Trends Pharmacol Sci. 1991 Mar;12(3):111-5. doi: 10.1016/0165-6147(91)90518-w. Trends Pharmacol Sci. 1991. PMID: 2053188 Review.

7

In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells.

Burnier M, Centeno G, Grouzmann E, Walker P, Waeber B, Brunner HR. Burnier M, et al. Among authors: grouzmann e. Am J Hypertens. 1991 May;4(5 Pt 1):438-43. doi: 10.1093/ajh/4.5.438. Am J Hypertens. 1991. PMID: 2069778

8

Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.

Waeber B, Nussberger J, Grouzmann E, Burnier M, Brunner HR. Waeber B, et al. Among authors: grouzmann e. Int J Rad Appl Instrum B. 1990;17(7):667-72. doi: 10.1016/0883-2897(90)90082-c. Int J Rad Appl Instrum B. 1990. PMID: 2148169 Review. No abstract available.

9

Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.

Grouzmann E, Gicquel C, Plouin PF, Schlumberger M, Comoy E, Bohuon C. Grouzmann E, et al. Cancer. 1990 Oct 15;66(8):1833-5. doi: 10.1002/1097-0142(19901015)66:8<1833::aid-cncr2820660831>3.0.co;2-9. Cancer. 1990. PMID: 2208039

10

Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors.

Grouzmann E, Comoy E, Bohuon C. Grouzmann E, et al. J Clin Endocrinol Metab. 1989 Apr;68(4):808-13. doi: 10.1210/jcem-68-4-808. J Clin Endocrinol Metab. 1989. PMID: 2466046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters